21 Followers on Owler

Boston Harbor Angels

Boston Harbor Angels invests in a high-growth, early-stage companies. Read more

Ziad H. Moukheiber's photo - CEO of Boston Harbor Angels

CEO

Ziad H. Moukheiber

CEO Approval Rating

74/100

Founded:

2004

Status:

Investment CompanyIndependent Company

BOSTON HARBOR ANGELS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Hyde Park Angels is Boston Harbor Angels's #1 competitor. Hyde Park Angels is a Investment Company company that was founded in 2007 in Chicago, Illinois. Hyde Park Angels is in the Diversified Investment Services industry. Compared to Boston Harbor Angels, Hyde Park Angels has 55 more employees.

MAA is seen as one of Boston Harbor Angels's biggest rivals. MAA was founded in Overland Park, Kansas} in 2006. MAA competes in the Investment Management & Fund Operators field. Compared to Boston Harbor Angels, MAA generates $2.8M more revenue.

Cornerstone Angels is one of Boston Harbor Angels's top competitors. Cornerstone Angels is headquartered in Northbrook, Illinois, and was founded in 2006. Cornerstone Angels is in the Investment Management & Fund Operators field. Cornerstone Angels generates 468% the revenue of Boston Harbor Angels.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Pritzker Group a competitor of Boston Harbor Angels?

Boston Harbor Angels Acquisitions

No recent acquisitions found related to Boston Harbor Angels

Boston Harbor Angels Funding History

No recent funding data found related to Boston Harbor Angels

Boston Harbor Angels Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Zylo Therapeutics is a biotechnology firm that designs and manufactures hydrogel-based drug-delivery systems.
$4M
Sep 25, 2019
Series A
-
Siamab is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$527K
Jun 29, 2014
Series B
-
ZetrOZ™ is an ultrasound technology company focused on developing a ultrasound products and applications.
$2M
Jun 11, 2014
Equity
-
Siamab is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$1.2M
Feb 04, 2014
Series B
-
Siamab is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$1M
Jul 29, 2013
Series B
-

Boston Harbor Angels News

February 5, 2014FINSMEs

Sialix Raises $1.2M

Sialix, Inc., a Cambridge, Massachusetts-based...... See more »

Boston Harbor Angels Blogs

June 7, 2021Boston Harbor Angels Blog

FAQ with Ziad H. Moukheiber

FAQ with Ziad H. Moukheiber What is Boston Harbor Angels? Boston Harbor Angels is an angel investing ... See more »
June 4, 2021Boston Harbor Angels Blog

Investor Roundtable: The Fundraising Journey

Investor Roundtable: The Fundraising Journey Hear firsthand from two founders, Laurel Taylor of Futur... See more »
June 2, 2021Boston Harbor Angels Blog

eSight Reaches New Milestone in Distribution, Availability of Advanced Low Vision Technology

Leading vision enhancement platform eSight announces it has grown its distribution network to reach m... See more »
June 1, 2021Boston Harbor Angels Blog

Elizabeth Banks Tries Luxury Wine in a Can | Archer Roose

Meet the uninvited guest, Elizabeth Banks... She just sort of showed up one day. And before we knew i... See more »
May 29, 2021Boston Harbor Angels Blog

What career women can learn from actor-filmmaker Elizabeth Banks

"I felt underused. I just knew there was more for me to be doing," the actress Elizabeth Banks once s... See more »
May 28, 2021Boston Harbor Angels Blog

Elizabeth Banks joins canned wine company Archer Roose

Leading canned wine company Archer Roose announced that Elizabeth Banks will be joining their team as... See more »
May 27, 2021Boston Harbor Angels Blog

Insider View: Wasabi CEO David Friend talks music, movies and minerals (Video)

Serial entrepreneur and Wasabi CEO David Friend spoke with BBJ Executive Editor about tech, music, mo... See more »

Boston Harbor Angels Press Releases

Social Media

Boston Harbor Angels Headquarters

Joy Street

Boston, Massachusetts02114

617-742-7887

Driving Directions »

Trending Companies

Boston Harbor Angels Summary

ABOUT

Overview

Boston Harbor Angels invests in a high-growth, early-stage companies. Boston Harbor Angels was founded in 2004. Boston Harbor Angels' headquarters is located in Boston, Massachusetts, USA 02114. Boston Harbor Angels' CEO, Ziad H. Moukheiber, currentl...

CEO

Boston Harbor Angels's CEO, Ziad H. Moukheiber, currently has an approval rating of 74%. Boston Harbor Angels's primary competitors are Hyde Park Angels, MAA & Cornerstone Angels.

Frequently Asked Questions about Boston Harbor Angels

  1. When was Boston Harbor Angels founded?

    Boston Harbor Angels was founded in 2004
  2. Who is Boston Harbor Angels's CEO?

    Boston Harbor Angels's CEO is Ziad H. Moukheiber
  3. How much revenue does Boston Harbor Angels generate?

    Boston Harbor Angels generates $3.2M in revenue
  4. How much funding does Boston Harbor Angels have?

    Boston Harbor Angels has historically raised $0 in funding
  5. Where is Boston Harbor Angels's headquarters?

    Boston Harbor Angels's headquarters is in Boston Massachusetts, USA
  1. How many employees does Boston Harbor Angels have?

    Boston Harbor Angels has 35 employees
  2. What sector does Boston Harbor Angels operate in?

    Boston Harbor Angels is in Diversified Investment Services
  3. Who are Boston Harbor Angels's competitors?

    Boston Harbor Angels's top competitors are Hyde Park Angels, MAA, Cornerstone Angels
  4. Who has Boston Harbor Angels invested in?

    Boston Harbor Angels's has invested in companies such as Zylo Therapeutics, Inc., Siamab Therapeutics, ZetrOZ